Jonathan Trent on Trabectedin for Soft Tissue Sarcoma
2 Просмотры
• 07/18/23
0
0
встраивать
administrator
Подписчики
Jonathan Trent, MD, PhD, associate director for clinical research, director of the Sarcoma Medical Research Program at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, discusses the approval of trabectedin (Yondelis) to treat patients with soft tissue sarcoma.
Показать больше
Комментарии Facebook
SORT BY-
Лучшие комментарии
-
Последние комментарии